259 related articles for article (PubMed ID: 29593498)
1. Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain.
Kandasamy M; Aigner L
Front Cell Neurosci; 2018; 12():37. PubMed ID: 29593498
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle re-entry of neurons and reactive neuroblastosis in Huntington's disease: Possibilities for neural-glial transition in the brain.
Manickam N; Radhakrishnan RK; Vergil Andrews JF; Selvaraj DB; Kandasamy M
Life Sci; 2020 Dec; 263():118569. PubMed ID: 33049278
[TBL] [Abstract][Full Text] [Related]
3. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
4. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.
Kandasamy M; Rosskopf M; Wagner K; Klein B; Couillard-Despres S; Reitsamer HA; Stephan M; Nguyen HP; Riess O; Bogdahn U; Winkler J; von Hörsten S; Aigner L
PLoS One; 2015; 10(2):e0116069. PubMed ID: 25719447
[TBL] [Abstract][Full Text] [Related]
5. Neuroplasticity, limbic neuroblastosis and neuro-regenerative disorders.
Kandasamy M; Aigner L
Neural Regen Res; 2018 Aug; 13(8):1322-1326. PubMed ID: 30106033
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of neuroregenerative plasticity in association with testicular atrophy and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis in Huntington's disease: A putative role of the huntingtin gene in steroidogenesis.
Selvaraj K; Manickam N; Kumaran E; Thangadurai K; Elumalai G; Sekar A; Radhakrishnan RK; Kandasamy M
J Steroid Biochem Mol Biol; 2020 Mar; 197():105526. PubMed ID: 31715317
[TBL] [Abstract][Full Text] [Related]
7. Possible Existence of the Hypothalamic-Pituitary-Hippocampal (HPH) Axis: A Reciprocal Relationship Between Hippocampal Specific Neuroestradiol Synthesis and Neuroblastosis in Ageing Brains with Special Reference to Menopause and Neurocognitive Disorders.
Kandasamy M; Radhakrishnan RK; Poornimai Abirami GP; Roshan SA; Yesudhas A; Balamuthu K; Prahalathan C; Shanmugaapriya S; Moorthy A; Essa MM; Anusuyadevi M
Neurochem Res; 2019 Aug; 44(8):1781-1795. PubMed ID: 31254250
[TBL] [Abstract][Full Text] [Related]
8. Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies?
Gil-Mohapel J; Simpson JM; Ghilan M; Christie BR
Brain Res; 2011 Aug; 1406():84-105. PubMed ID: 21742312
[TBL] [Abstract][Full Text] [Related]
9. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
Smail S; Bahga D; McDole B; Guthrie K
Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease.
Parent M; Bédard C; Pourcher E
Am J Neurodegener Dis; 2013; 2(3):221-7. PubMed ID: 24093085
[TBL] [Abstract][Full Text] [Related]
11. The neurodegenerative process in a neurotoxic rat model and in patients with Huntington's disease: histopathological parallels and differences.
Gunčová I; Látr I; Mazurová Y
Acta Histochem; 2011 Dec; 113(8):783-92. PubMed ID: 21193226
[TBL] [Abstract][Full Text] [Related]
12. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
[TBL] [Abstract][Full Text] [Related]
13. The Regulation of Reactive Neuroblastosis, Neuroplasticity, and Nutraceuticals for Effective Management of Autism Spectrum Disorder.
Poornimai Abirami GP; Radhakrishnan RK; Johnson E; Roshan SA; Yesudhas A; Parveen S; Biswas A; Ravichandran VR; Muthuswamy A; Kandasamy M
Adv Neurobiol; 2020; 24():207-222. PubMed ID: 32006362
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
15. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease.
Dogan I; Eickhoff CR; Fox PT; Laird AR; Schulz JB; Eickhoff SB; Reetz K
Neuroimage Clin; 2015; 7():640-52. PubMed ID: 25844318
[TBL] [Abstract][Full Text] [Related]
16. Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.
Mazurová Y; Gunčová I; Látr I; Rudolf E
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):486-99. PubMed ID: 21495959
[TBL] [Abstract][Full Text] [Related]
17. Subventricular zone lipidomic architecture loss in Huntington's disease.
Hunter M; Demarais NJ; Faull RLM; Grey AC; Curtis MA
J Neurochem; 2018 Sep; 146(5):613-630. PubMed ID: 29804301
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice.
Song M; Yu SP; Mohamad O; Cao W; Wei ZZ; Gu X; Jiang MQ; Wei L
Neurobiol Dis; 2017 Feb; 98():9-24. PubMed ID: 27884724
[TBL] [Abstract][Full Text] [Related]
19. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
20. Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols.
Sassone J; Papadimitriou E; Thomaidou D
Front Neurosci; 2018; 12():800. PubMed ID: 30450032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
